SCHEMBL6924418

SCHEMBL6924418

CNCCOc1cccc2c1c1ccccc1n2Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 2/20 0.51
HTR1D P28221 1/20 0.51
CYP19A1 P11511 1/20 0.49
UTS2R Q9UKP6 1/20 0.48
HRH1 P35367 2/20 0.47
SLC6A4 P31645 2/20 0.47
HTR6 P50406 5/20 0.46
P2RX4 Q99571 1/20 0.44
PLA2G2A P14555 4/20 0.43
MCL1 Q07820 1/20 0.43
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926722 0.89 HTR6 (0.48) HTR1BHTR1DCYP19A1HRH1HTR6
SCHEMBL6921216 0.88 HTR1B (0.53) HTR1BCYP19A1UTS2RHTR6P2RX4
SCHEMBL6925119 0.87 HTR1B (0.54) HTR1BCYP19A1UTS2RHTR6P2RX4
SCHEMBL6921654 0.87 HTR6 (0.49) HTR1BCYP19A1UTS2RHTR6
SCHEMBL6925648 0.85 KDM4E (0.56) UTS2RHTR6PLA2G2AMCL1
SCHEMBL6925519 0.84 HTR6 (0.51) CYP19A1UTS2RHTR6P2RX4PLA2G2A
SCHEMBL6928704 0.84 HTR1D (0.54) HTR1BHTR1DCYP19A1UTS2RHTR6
SCHEMBL6927422 0.83 CYP19A1 (0.44) CYP19A1UTS2RSLC6A4HTR6P2RX4
SCHEMBL6921144 0.83 CYP19A1 (0.53) HTR1BCYP19A1UTS2RHTR6P2RX4
SCHEMBL6920951 0.83 CYP19A1 (0.53) CYP19A1UTS2RHTR6P2RX4PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US claimed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP claimed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO claimed
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed